Cancer Remission vs. Recurrence: Definitions, Types & Surveillance

Remission Definitions

• Complete remission (CR): All detectable cancer gone (imaging, exam, markers). **Not cure** – microscopic disease may persist.
• Partial remission (PR): ≥30% decrease in target lesions (RECIST), but disease remains.
• Stable disease (SD): Neither PR nor progression.
• Molecular remission / MRD-negative: No detectable cancer DNA (ctDNA) or cells (flow cytometry) – deeper than imaging.

Recurrence (Relapse)

• Local: Same organ/site.
• Regional: Lymph nodes.
• Distant (metastatic): New organs.
• Can occur months to decades later (dormancy).

Why Recurrence Happens After CR

• **Minimal residual disease (MRD):** Below detection limit.
• **Cancer stem cells:** Quiescent, therapy-resistant.
• **Microenvironment:** Niche protection, immune evasion.
• **Clonal evolution:** New mutations confer resistance.

Surveillance Strategy

• Risk-adapted: Cancer type, stage, biology, treatment received.
• History, exam, labs (tumor markers), imaging (CT, PET, MRI) at defined intervals.
• Emerging: **ctDNA liquid biopsy** detects recurrence months before imaging.
• Duration: Often 5–10 years; some lifelong (melanoma, breast, thyroid).

Survivorship Care

• Late effects monitoring (cardiotoxicity, second cancers, endocrine, cognitive).
• Psychosocial support (fear of recurrence).
• Health promotion (exercise, diet, vaccination, screening).

Remission is a milestone, not a finish line. Vigilance + hope.